$510M overspent on dialysis drugs: OIG

The CMS and Medicare beneficiaries could have saved an estimated $510 million on drugs used to treat end-stage renal disease in 2011 if the reimbursement rate more accurately reflected current usage of these drugs, according to a new report from HHS' inspector general's office .

http://www.modernhealthcare.com/article/20130510/NEWS/305109969